Our observations with kidney cancer subtypes further illustrated the specificity of our approach, as papillary and chromophobe carcinomas showed underexpression of FOLH1 relative to normal kidney tissue, consistent with studies that showed poor uptake and tumor-to-background ratio in these tumor types [4,15]. The gene discussed is FOLH1; the disease is kidney cancer.